Testing the Addition of an Investigational Drug, Xevinapant, to Usual Radiation Therapy Plus Cisplatin/Carboplatin for Patients With Head and Neck Cancer
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
Vanderbilt-Ingram Cancer Center
Eastern Cooperative Oncology Group
Mayo Clinic
University of California, San Francisco
National Cancer Institute (NCI)